Maxim Group Cuts SWK (NASDAQ:SWKH) Price Target to $18.00

SWK (NASDAQ:SWKH) had its target price dropped by research analysts at Maxim Group from $21.00 to $18.00 in a research note issued on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Maxim Group’s target price would suggest a potential upside of 27.25% from the company’s current price.

SWK Price Performance

NASDAQ:SWKH traded down $0.11 during mid-day trading on Monday, reaching $14.15. The stock had a trading volume of 11,686 shares, compared to its average volume of 13,151. The firm has a 50 day moving average price of $16.12 and a two-hundred day moving average price of $16.28. SWK has a one year low of $13.17 and a one year high of $20.49. The stock has a market capitalization of $173.56 million, a P/E ratio of 15.21 and a beta of 0.21. The company has a debt-to-equity ratio of 0.11, a quick ratio of 5.06 and a current ratio of 5.06.

SWK (NASDAQ:SWKH) last announced its earnings results on Thursday, May 15th. The company reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.37. SWK had a return on equity of 5.07% and a net margin of 26.51%. The business had revenue of $11.83 million for the quarter.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the company. Rangeley Capital LLC acquired a new position in SWK during the fourth quarter worth $692,000. Dynamic Advisor Solutions LLC acquired a new position in shares of SWK in the first quarter worth about $378,000. M3F Inc. increased its holdings in SWK by 2.5% in the fourth quarter. M3F Inc. now owns 800,151 shares of the company’s stock valued at $12,690,000 after buying an additional 19,279 shares during the last quarter. Millennium Management LLC bought a new stake in SWK in the fourth quarter valued at about $235,000. Finally, JPMorgan Chase & Co. grew its holdings in shares of SWK by 102.2% during the fourth quarter. JPMorgan Chase & Co. now owns 12,350 shares of the company’s stock valued at $196,000 after purchasing an additional 6,242 shares during the last quarter. Hedge funds and other institutional investors own 99.27% of the company’s stock.

SWK Company Profile

SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.